Discovery of GS-9451: an acid inhibitor of the hepatitis C virus NS3/4A protease.

[1]  Geoffrey Dusheiko,et al.  Telaprevir for previously untreated chronic hepatitis C virus infection. , 2011, The New England journal of medicine.

[2]  A. Kwong,et al.  Recent progress in the development of selected hepatitis C virus NS3.4A protease and NS5B polymerase inhibitors. , 2008, Current opinion in pharmacology.

[3]  F. G. Njoroge,et al.  Challenges in modern drug discovery: a case study of boceprevir, an HCV protease inhibitor for the treatment of hepatitis C virus infection. , 2008, Accounts of chemical research.

[4]  J. Sheldon,et al.  Novel protease and polymerase inhibitors for the treatment of hepatitis C virus infection , 2007, Expert opinion on investigational drugs.

[5]  S. Zeuzem,et al.  Rapid decline of viral RNA in hepatitis C patients treated with VX-950: a phase Ib, placebo-controlled, randomized study. , 2006, Gastroenterology.

[6]  N. Butkiewicz,et al.  SCH 503034, a Mechanism-Based Inhibitor of Hepatitis C Virus NS3 Protease, Suppresses Polyprotein Maturation and Enhances the Antiviral Activity of Alpha Interferon in Replicon Cells , 2006, Antimicrobial Agents and Chemotherapy.

[7]  R. Francesco,et al.  Challenges and successes in developing new therapies for hepatitis C , 2005, Nature.

[8]  Steven R. LaPlante and Montse Llinàs-Brunet.  Dynamics and Structure-based Design of Drugs Targeting the Critical Serine Protease of the Hepatitis C Virus - From a Peptidic Substrate to BILN 2061 , 2005 .

[9]  C. Brochu,et al.  Potent inhibitors of the hepatitis C virus NS3 protease: design and synthesis of macrocyclic substrate-based beta-strand mimics. , 2004, The Journal of organic chemistry.

[10]  Steven R. LaPlante,et al.  An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus , 2003, Nature.

[11]  P. Bonneau,et al.  Macrocyclic inhibitors of the NS3 protease as potential therapeutic agents of hepatitis C virus infection. , 2003, Angewandte Chemie.

[12]  M. Houghton,et al.  Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. , 1989, Science.